Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

PSNC North-East and Cumbria regional representative Mark Burdon resigns

The Pharmaceutical Services Negotiating Committee (PSNC)'s North-East and Cumbria regional representative, Mark Burdon, has resigned from his role. The Committee has invited all eligible independent contractors to fulfil the post.

The new regional representative will be asked to hold the position until the end of the current term for all Regional Representatives which is now March 31, 2023.


“A representative of independent contractors in the following Local Pharmaceutical Committee (LPC) areas will be sought: · Community Pharmacy County Durham · Community Pharmacy Cumbria · Gateshead & South Tyneside LPC · North of Tyne LPC · Sunderland LPC · Tees LPC,” said PSNC.

Eligible independent contractors from these LPC areas are invited to express their interest in the role and then, if an election is triggered, to vote to select their new regional representative in due course -- PSNC will issue a full briefing on this process.

Further information, including details about the role of regional representative, the election process, actions required for those seeking to stand for election and timescales, will be shared by the committee with the relevant LPCs and contractors in due course.

In the meantime, PSNC has asked any contractors or LPCs in the North-East and Cumbria region needing assistance should contact PSNC director of Contractor and LPC Support, James Wood.

Janet Morrison, PSNC CEO, said: “From the short time that I have spent with them so far, I can already see the very important role that the PSNC regional representatives play in bringing the voice of independent contractors to the heart of all PSNC work and decision-making. This will continue to be critical, and I look forward to working with our new Regional Representative from North-East and Cumbria in due course.

"Mark has spent an impressive 16 years as a regional representative, during which time I understand he has worked tirelessly to represent the independent contractors in his region. Mark has been an enthusiastic contributor to many important PSNC workstreams, subcommittees and working groups, including chairing our Resource, Development and Finance subcommittee and leading on many of our wider and international sector relationships. He has also been a familiar face across parliament and in the national media, advocating widely for all that community pharmacy has to offer. We wish him all the best for the future.”

Mark Burdon said: “My time at PSNC has been both challenging and hugely enjoyable, and I will miss working with committee members and the executive team at PSNC. But I had always planned to leave PSNC at the end of my current term due to end in 2022, and with the worst of the Covid-19 pandemic now over, a new chief executive in post at PSNC, and the Review Steering Group concluding its work, the time is still right for me to stand down. I wish everyone at PSNC the very best, and I will look forward to supporting the new regional representative for our area in any way that I can. I will be continuing in my RSG and LPC roles.”

More For You

NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less